Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrheaNovember 22, 2019Women's HealthPainEndocrinology
Findings confirm link between methimazole and risk for acute pancreatitisNovember 21, 2019EndocrinologyGastroenterology
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabeticsNovember 17, 2019DiabetesCardiologyEndocrinology
FDA panel supports Vascepa expanded indication for CVD reductionNovember 14, 2019Preventive CareCardiologyEndocrinology
Small nodules, big problems: AI's role in thyroid nodule diagnosisNovember 11, 2019EndocrinologyOncology
New model for CKD risk draws on clinical, demographic factorsNovember 8, 2019DiabetesNephrologyEndocrinology
Levothyroxine dose for checkpoint inhibitor toxicity may be too highNovember 4, 2019EndocrinologyOncology
Hormone therapy in transgender patients is safe for boneOctober 23, 2019Transgender HealthEndocrinologyMusculoskeletal Disorders
Dapagliflozin approved for reducing HF hospitalization in diabetesOctober 21, 2019DiabetesCardiologyEndocrinology
Certain diabetes drugs may thwart dementiaOctober 21, 2019DiabetesAlzheimer's & CognitionNeurologyEndocrinologyMental Health
Take drug, patient-level factors into account for when to end antiresorptive therapyOctober 18, 2019RheumatologyEndocrinology
Multiple zoledronic acid doses may be needed after stopping denosumabOctober 14, 2019EndocrinologyRheumatology
Consider cognitive reframing of osteoporosis to improve adherenceOctober 3, 2019EndocrinologyRheumatology
